Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Nordic Pharma SAS
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult patient, ambulatory, seen in a rheumatology consultation.
With a confirmed diagnosis of RA (ACR 1987 or ACR/EULAR 2010 criteria) receiving a disease-modifying treatment with methotrexate as a monotherapy.
With clinical, functional, structural and/or therapeutic disease progression, for whom the rheumatologist intends to change the therapeutic treatment of the RA .
Informed about the computer processing of their medical data and their right of access and correction.
You may not be if
Patient not treated with methotrexate for their RA.
Already treated with a biotherapy or receiving other synthetic DMARDs (disease-modifying antirheumatic drugs) in combination with methotrexate .
Participating in a clinical trial in rheumatology.
Clareo Health | Therapeutic Strategy in Patients Treated With Methotrexate for Rheumatoid Arthritis
